MarketsNotableSingle-sourceDeveloping
5.1
Onfolio Holdings Receives Nasdaq Delisting Notice
SEC EDGAR 8-K FilingsLO·US·1 day ago
Rein Therapeutics, Inc. filed an 8-K disclosing a notice of delisting or failure to satisfy continued listing standards. The specific exchange and the nature of the non-compliance remain unspecified in the filing summary, signaling potential financial or regulatory distress for the issuer.